Cargando…
Pharmacological Treatment of Secondary Lymphedema
Lymphedema is a chronic disease that results in swelling and decreased function due to abnormal lymphatic fluid clearance and chronic inflammation. In Western countries, lymphedema most commonly develops following an iatrogenic injury to the lymphatic system during cancer treatment. It is estimated...
Autores principales: | Brown, Stav, Dayan, Joseph H., Coriddi, Michelle, Campbell, Adana, Kuonqui, Kevin, Shin, Jinyeon, Park, Hyeung Ju, Mehrara, Babak J., Kataru, Raghu P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8822213/ https://www.ncbi.nlm.nih.gov/pubmed/35145417 http://dx.doi.org/10.3389/fphar.2022.828513 |
Ejemplares similares
-
The Future of Lymphedema: Potential Therapeutic Targets for Treatment
por: Brown, Stav, et al.
Publicado: (2023) -
148. Extravasated Lymph from Secondary Lymphedema Patients Increases Cellular Permeability and Decreases Lymphatic Endothelial Cell VEGFR3 Expression
por: Kuonqui, Kevin, et al.
Publicado: (2023) -
Skin microbiome alterations in upper extremity secondary lymphedema
por: Campbell, Adana-Christine, et al.
Publicado: (2023) -
154. Non-invasive Detection of Subclinical Skin Changes in Lymphedema: A Promising Screening Method for Early Stage Disease
por: Brown, Stav, et al.
Publicado: (2023) -
PC32. Non-invasive Detection of Subclinical Skin Changes in Lymphedema: A Promising Screening Method for Early Stage Disease
por: Brown, Stav, et al.
Publicado: (2023)